GILEAD SCIENCES, INC. (GILD)
Biological Products, (No Diagnostic Substances) · Healthcare · $158.0B
Intrinsic Value (Consensus)
$176.92
Current Price
$127.23
Margin of Safety
+39.1%
39.1% Below Intrinsic Value
Value: $177
Price: $127
Valuation Model Estimates
Current Price: $127.23
DCF (Discounted Cash Flow)
$357.03
Graham Number
$52.81
Earnings Power Value
$65.83
Relative Value (P/E)
$135.60
Dividend Discount Model
$273.33
Consensus Value
$176.92
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
75
Profitability
25/25
Strength
15/25
Valuation
22/25
Growth
13/25
Financial Health Signals
Elevated debt — Debt/Equity ratio is 110%
Strong profitability — ROE of 37% (above 20% is excellent)
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $6.78
- EPS (Forward)
- $8.14
- Book Value
- $18.28
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 37.5%
- Debt/Equity
- 110%
- Revenue Growth
- 2.4%
- Earnings Growth
- 20.0%
- Dividend Yield
- 0.6%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance